share_log

UBS Downgrades GSK to Neutral

Benzinga ·  21:32

UBS analyst Jo Walton downgrades GSK (NYSE:GSK) from Buy to Neutral.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment